期刊文献+

FK506对糖尿病小鼠胰岛移植物功能及再血管化的影响

Effects of FK506 on function and revascularization of islet grafts in diabetic mice
下载PDF
导出
摘要 目的探讨小鼠胰岛移植术后服用他克莫司(FK506)对胰岛移植物生物学功能及再血管化的影响。方法小鼠胰腺经胶原酶P灌注消化后,Ficoll.400不连续密度梯度离心提纯并培养制备供体胰岛。1型糖尿病受体小鼠接受肾被膜下胰岛移植并分成两组:单纯同系基因胰岛移植组(PIT组)和同系基因胰岛移植后加用FK506组(PIT+FK506组)。监测受体小鼠血糖浓度的变化,观察移植物组织学形态、胰岛素分泌功能及新生血管生成情况。结果两组小鼠各时间点血糖浓度的变化差异无统计学意义(P〉0.05)。组织形态学观察发现两组小鼠胰岛移植物均存活良好,无明显差别。移植后第3~5天和第20天,PIT+FK506组移植物血管内皮生长因子(VEGF)和CD34表达均较PIT组有所降低;PIT组肾被膜下移植物微血管密度分别为16.6±1.3和96.7±2.3,PIT+FK506组分别为9.3±1.0和61.0±2.7,相同时间点两组间比较差异有统计学意义(P〈0.05)。结论治疗剂量的FK506可在一定程度上抑制胰岛移植物的再血管化,但不会直接影响胰岛细胞的生物学功能。 Objective To: investigate effects of FK506 on function and revascularization of transplanted islets after pancreatic islet transplantation (PIT) in diabetic mice. Methods Pancreatic islets of donor mice were obtained by infusion of eollagenase P solution with pancreatic duct and Ficoll-400 density gradient eentrifugation, then transplanted into renal capsule of type 1 diabetic mice. The recipients were divided into two groups: control group (PIT group) and FK506- treated group ( PIT + FK506 group). The blood glucose of recipients mice after islet transplantation were monitored. The histological feature, function of insulin secretion, and revascularization of the grafts were observed. Results The blood glucose on each time point had no significant differences between PIT group and PIT + FK506 group ( P 〉 0.05). Histological examination showed that all the islet grafts survived well and had no difference. On day 3 -5 and 20 after PIT, compared to PIT group, VEGF and CD34 expressions were significantly lower in PIT + FK506 group. On day 3 - 5 and 20 after PIT, the newly-formed microvascular density of renal subcapsular islet grafts post transplantation !n PIT + FK506 group (9.3±1.0 and 61.0±2.7) were significantly lower than those in PIT group (16.6± 1.3 and 96.7±2.3)(P 〈0.05). Conclusion The therapeutic dose of FK506 inhibits the revascularization of transplanted pancreatic islets, but does not affect the insulin secretion of the transplanted grafts directly.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2013年第12期1573-1578,共6页 Journal of Shanghai Jiao tong University:Medical Science
基金 国家自然科学基金(30972945) 重庆市科委基金(CSTC2007 BB5263)~~
关键词 糖尿病 胰岛移植 再血管化 FK506 小鼠 diabetes islet transplantation revascularization mouse FK506
  • 相关文献

参考文献25

  • 1Shapiro AM, LakeyJR, Ryan EA, et aI. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid?free immunosuppressive regimen[J]. N EnglJ Med, 2000, 343 ( 4 ) : 230 - 238.
  • 2Carlsson PO, Palm F, Mattsson G, et aI. Low revascularization of experimentally transplanted human pancreatic islets[J].J Clin Endocrinol Metab, 2002, 87(12): 5418 -5423.
  • 3Mattsson G,Jansson L, Carlsson PO. Decreased vascular density in mouse pancreatic islets after transplantation[J]. Diabetes, 2002, 51 ( 5): 1362 - 1366.
  • 4Carlsson PO, Palm F, Andersson A, et al. Markedly decreased oxygen tension in transplanted rat pancreatic islets irrespective of the implantation site[Jl. Diabetes, 2001, 50(3) : 489 -495.
  • 5Zhang N, Su D, Qu S, et al. Sirolimus is associated with reduced islet engraftment and impaired beta-cell function[J]. Diabetes, 2006, 55 (9) : 2429 - 2436.
  • 6Guba M, von Breitenbuch P, Steinbauer M, et al. Rapamyein inhibits primary and metastatic tumor growth by antiangiogenesis , involvement of vascular endothelial growth factor[J]. Nat Med, 2002, 8 (2) : 128 - 135.
  • 7Cross SE, Richards SK, Clark A, et al. Vascular endothelial growth factor as a survival factor for human islets: effect of immunosuppres?sive drugsj L}. Diabetologia, 2007,50(7): 1423 -1432.
  • 8Cantaluppi V, Biancone L, Romanazzi GM, et al. Antiangiogenic and immunomodulatory effects of rapamycin on islet endothelium: relevance for islet transplantation[J]. AmJ Transplant, 2006, 6 (II): 2601 -2611.
  • 9Turgut B, Guier M, Akpolat N, et al. The impact of tacrolimus on vascular endothelial growth factor in experimental corneal neovascu?larization[J]. Curr Eye Res, 2011, 36( 1): 34 -40.
  • 10中华人民共和国科学技术部.关于善待实验动物的指导性意见[S].2006.9.

二级参考文献19

  • 1Gillespie KM.Type 1 diabetes:pathogenesis and prevention[J].CMAJ,2006,175(2):165-170.
  • 2von Herrath M,Sanda S,Herold K.Type 1 diabetes as a relapsing-remitting disease?[J]Nat Rev Immunol,2007,7(12):988-994.
  • 3Jaramillo A,Gill BM,Delovitch TL.Insulin-dependent diabetesmellitus in the non-obese diabetic mouse:a disease mediated by Tcell anergy?[J]Life Sci,1994,55(15):1163-1177.
  • 4Balamurugan AN,Bottino R,Giannoukakis N,et al.Prospective andchallenges of islet transplantation for the therapy of autoimmunediabetes[J].Pancreas,2006,32(3):231-243.
  • 5Nanji SA,Shapiro AM.Advances in pancreatic islet transplantationin humans[J].Diabetes Obes Metab,2006,8(1):15-25.
  • 6Balamurugan AN,Bottino R,Giannoukakis N,et al.Prospectiveand challenges of islet transplantation for the therapy of autoimmunediabetes[J].Pancreas,2006,2(3):231-243.
  • 7Rajab A.Islet transplantation:alternative sites[J].Curr Diab Rep,2010,10(5):332-337.
  • 8Salazar-Bauelos A,Benitez-Bribiesca L,Sigalet DL,et al.Bonemarrow as a site for pancreatic islet transplantation[J].Blood,2010,115(17):3643-3644.
  • 9Perez VL,Caicedo A,Berman DM,et al.The anterior chamber ofthe eye as a clinical transplantation site for the treatment of diabetes:a study in a baboon model of diabetes[J].Diabetologia,2011,54(5):1121-1126.
  • 10Li DS,Yuan YH,Tu HJ,et al.A protocol for islet isolation frommouse pancreas[J].Nat Protoc,2009,4(11):1649-1652.

共引文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部